NSCLC脑转移-话题@MedSci

#NSCLC脑转移#

15篇内容 | 1158人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2251797, encodeId=c1c32251e9796, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a> 非小细胞肺癌（NSCLC）脑转移（BM）是晚期 NSCLC 患者常见的并发症，严重影响预后和生活质量。目前，一线化疗对脑转移的治疗效果有限，迫切需要更有效的治疗策略。免疫检查点抑制剂（ICIs）在驱动基因阴性晚期 NSCLC 的一线治疗中展现出显著的生存获益，并显示出在 NSCLC 脑转移治疗中的潜在应用价值。CTONG 2003 研究旨在评估卡瑞利珠单抗联合放疗和化疗在未经治疗的驱动基因阴性 NSCLC 脑转移患者中的疗效和安全性。, objectTitle=NSCLC脑转移, objectType=topic, longId=13079, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=2, createdTime=2025-02-13, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, status=1, hasArticle=0, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2251773, encodeId=6b772251e73a8, content=<a href='/topic/show?id=4d185e31825' target=_blank style='color:#2F92EE;'>#放化疗#</a> <a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a> <a href='/topic/show?id=1f883652ea9' target=_blank style='color:#2F92EE;'>#卡瑞利珠单抗#</a>, objectTitle=J Thorac Oncol | NSCLC 脑转移治疗新进展：CTONG 2003 研究评估卡瑞利珠单抗联合放化疗的疗效, objectType=article, longId=863118, objectId=218886311814, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241211/1733884338561_8538692.png, objectUrl=/article/show_article.do?id=218886311814, replyNumber=0, likeNumber=18, createdTime=2025-02-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=218886311814, moduleTitle=J Thorac Oncol | NSCLC 脑转移治疗新进展：CTONG 2003 研究评估卡瑞利珠单抗联合放化疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=218886311814)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1989527, encodeId=052b198952e82, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=DCE-MRI和DWI对NSCLC脑转移的预测, objectType=article, longId=217205, objectId=cbe021e205d4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbe021e205d4, replyNumber=0, likeNumber=77, createdTime=2021-12-01, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbe021e205d4, moduleTitle=DCE-MRI和DWI对NSCLC脑转移的预测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbe021e205d4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989526, encodeId=1a6419895267a, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效 , objectType=article, longId=217043, objectId=644421e04318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=644421e04318, replyNumber=0, likeNumber=79, createdTime=2022-08-08, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=644421e04318, moduleTitle=J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=644421e04318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989525, encodeId=21e319895252d, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=AACR 2020：Capmatinib治疗MET 14突变的NSCLC脑转移疗效, objectType=article, longId=193158, objectId=b7d619315856, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7d619315856, replyNumber=0, likeNumber=72, createdTime=2020-05-23, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7d619315856, moduleTitle=AACR 2020：Capmatinib治疗MET 14突变的NSCLC脑转移疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7d619315856)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989524, encodeId=668319895244b, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=Lancet Onocol：NSCLC脑转移的免疫治疗依赖PD-L1表达, objectType=article, longId=191515, objectId=c8b119151594, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8b119151594, replyNumber=0, likeNumber=85, createdTime=2021-02-24, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8b119151594, moduleTitle=Lancet Onocol：NSCLC脑转移的免疫治疗依赖PD-L1表达, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8b119151594)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989523, encodeId=30551989523fe, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略, objectType=article, longId=178512, objectId=7fb11e8512e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fb11e8512e3, replyNumber=0, likeNumber=105, createdTime=2020-04-03, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fb11e8512e3, moduleTitle=【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fb11e8512e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989522, encodeId=6853198952297, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=CSCO 2018 | NSCLC脑转移真实世界治疗的讨论, objectType=article, longId=149439, objectId=1fea14943986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fea14943986, replyNumber=0, likeNumber=0, createdTime=2019-02-17, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fea14943986, moduleTitle=CSCO 2018 | NSCLC脑转移真实世界治疗的讨论, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fea14943986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989517, encodeId=145f198951e61, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=内科、放疗科专家共话NSCLC脑转移的治疗进展, objectType=article, longId=120331, objectId=f27612033159, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f27612033159, replyNumber=0, likeNumber=71, createdTime=2018-03-07, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f27612033159, moduleTitle=内科、放疗科专家共话NSCLC脑转移的治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f27612033159)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989515, encodeId=96f21989515c6, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=《柳叶刀》子刊发表研究成果，吴一龙教授点明NSCLC脑转移靶向治疗的未来探索方向, objectType=article, longId=106567, objectId=e58b10656e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e58b10656e78, replyNumber=0, likeNumber=102, createdTime=2017-11-30, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e58b10656e78, moduleTitle=《柳叶刀》子刊发表研究成果，吴一龙教授点明NSCLC脑转移靶向治疗的未来探索方向, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e58b10656e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989521, encodeId=83231989521fc, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=Ann Oncol：奥希替尼治疗T790M阳性NSCLC脑转移：两项II期研究合并分析, objectType=article, longId=129881, objectId=12e61298813e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12e61298813e, replyNumber=0, likeNumber=120, createdTime=2018-08-02, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12e61298813e, moduleTitle=Ann Oncol：奥希替尼治疗T790M阳性NSCLC脑转移：两项II期研究合并分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12e61298813e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989516, encodeId=0dea1989516fc, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=J Thorac Oncol：NSCLC脑转移∣一文掌握现阶段WBRT的地位和应用, objectType=article, longId=107140, objectId=c34a10e140db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c34a10e140db, replyNumber=0, likeNumber=98, createdTime=2018-04-25, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c34a10e140db, moduleTitle=J Thorac Oncol：NSCLC脑转移∣一文掌握现阶段WBRT的地位和应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c34a10e140db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989519, encodeId=1c0a198951900, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=【专家访谈】NSCLC脑转移和脑膜转移的处理, objectType=article, longId=121561, objectId=b7bf12156198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7bf12156198, replyNumber=0, likeNumber=90, createdTime=2018-04-16, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7bf12156198, moduleTitle=【专家访谈】NSCLC脑转移和脑膜转移的处理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7bf12156198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989514, encodeId=24a2198951450, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=JCO：EGFR突变型NSCLC脑转移患者的治疗策略, objectType=article, longId=99333, objectId=ac4999333a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac4999333a5, replyNumber=0, likeNumber=84, createdTime=2017-07-07, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac4999333a5, moduleTitle=JCO：EGFR突变型NSCLC脑转移患者的治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac4999333a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989520, encodeId=d749198952058, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=J Thorac Oncol：放疗外科治疗驱动基因阳性多发NSCLC脑转移, objectType=article, longId=129876, objectId=38a11298e67e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38a11298e67e, replyNumber=0, likeNumber=120, createdTime=2018-08-18, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38a11298e67e, moduleTitle=J Thorac Oncol：放疗外科治疗驱动基因阳性多发NSCLC脑转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38a11298e67e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1989518, encodeId=cd2319895187e, content=<a href='/topic/show?id=383e130e9de' target=_blank style='color:#2F92EE;'>#NSCLC脑转移#</a>, objectTitle=陆舜教授、王绿化教授和张力教授访谈：如何处理有症状NSCLC脑转移和无症状脑转移？, objectType=article, longId=120476, objectId=e95a1204e62b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e95a1204e62b, replyNumber=0, likeNumber=76, createdTime=2017-12-29, rootId=0, userName=tonychen21, userId=ac1c235, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e95a1204e62b, moduleTitle=陆舜教授、王绿化教授和张力教授访谈：如何处理有症状NSCLC脑转移和无症状脑转移？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e95a1204e62b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

NSCLC脑转移

2020-05-29

yangchou

全文收起 #NSCLC脑转移# 非小细胞肺癌（NSCLC）脑转移（BM）是晚期 NSCLC 患者常见的并发症，严重影响预后和生活质量。目前，一线化疗对脑转移的治疗效果有限，迫切需要更有效的治疗策略。免疫检查点抑制剂（ICIs）在驱动基因阴性晚期 NSCLC 的一线治疗中展现出显著的生存获益，并显示出在 NSCLC 脑转移治疗中的潜在应用价值。CTONG 2003 研究旨在评估卡瑞利珠单抗联合放疗和化疗在未经治疗的驱动基因阴性 NSCLC 脑转移患者中的疗效和安全性。

2025-02-13发表于浙江省

梅斯管理员

#放化疗# #NSCLC脑转移# #卡瑞利珠单抗#

J Thorac Oncol | NSCLC 脑转移治疗新进展：CTONG 2003 研究评估卡瑞利珠单抗联合放化疗的疗效

2025-02-13发表于陕西省

tonychen21

#NSCLC脑转移#

DCE-MRI和DWI对NSCLC脑转移的预测

2021-12-01

tonychen21

#NSCLC脑转移#

J Thorac Oncol：CNS渗透性TKI单药vs TKI+放疗治疗EGFR/ALK阳性NSCLC脑转移患者的疗效

2022-08-08

tonychen21

#NSCLC脑转移#

AACR 2020：Capmatinib治疗MET 14突变的NSCLC脑转移疗效

2020-05-23

tonychen21

#NSCLC脑转移#

Lancet Onocol：NSCLC脑转移的免疫治疗依赖PD-L1表达

2021-02-24

tonychen21

#NSCLC脑转移#

【CNS学院·大咖说】刘安文教授： EGFR突变阳性晚期NSCLC脑转移防治策略

2020-04-03

tonychen21

#NSCLC脑转移#

CSCO 2018 | NSCLC脑转移真实世界治疗的讨论

2019-02-17

tonychen21

#NSCLC脑转移#

内科、放疗科专家共话NSCLC脑转移的治疗进展

2018-03-07

tonychen21

#NSCLC脑转移#

《柳叶刀》子刊发表研究成果，吴一龙教授点明NSCLC脑转移靶向治疗的未来探索方向

2017-11-30

tonychen21

#NSCLC脑转移#

Ann Oncol：奥希替尼治疗T790M阳性NSCLC脑转移：两项II期研究合并分析

2018-08-02

tonychen21

#NSCLC脑转移#

J Thorac Oncol：NSCLC脑转移∣一文掌握现阶段WBRT的地位和应用

2018-04-25

tonychen21

#NSCLC脑转移#

【专家访谈】NSCLC脑转移和脑膜转移的处理

2018-04-16

tonychen21

#NSCLC脑转移#

JCO：EGFR突变型NSCLC脑转移患者的治疗策略

2017-07-07

tonychen21

#NSCLC脑转移#

J Thorac Oncol：放疗外科治疗驱动基因阳性多发NSCLC脑转移

2018-08-18

tonychen21

#NSCLC脑转移#

陆舜教授、王绿化教授和张力教授访谈：如何处理有症状NSCLC脑转移和无症状脑转移？

2017-12-29